5.0. Conclusion
Drug use continues to be a major concern in urban centers and significantly affects the health of cities at the beginning of the new millennium. Drug users still face considerable challenges to their health and well-being. The extent to which the urban environment affects the occurrence of drug use and its consequences is an area of growing research. Early investigations suggest that specific features of the urban environment are related to not only the occurrence of drug use, but also its course and consequences. Many questions remain unanswered with respect to the impact of the urban social and physical environment, along with larger societal structures, on illicit drug use. Because of the large number of drug users in urban areas, cities provide a unique opportunity for public health practitioners, urban planners, and policy makers to develop and test creative programs and interventions to improve the health outcomes for this population.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abraham, M. D. (1999). Illicit drug use, urbanization, and lifestyle in the Netherlands. J. Drug Issues 29:565–586.
Aitken, C., Brough, R., and Crofts, N. (1999). Injecting drug use and blood-borne viruses: a comparison of rural and urban Victoria, 1990–95. Drug Alcohol Rev. 18:47–52.
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R.A., and Margolis, H.S. (1999). The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N. Engl. J. Med. 341:556–562.
Anglin, M. D., Hser, Y. I., and McGlothlin, W. H. (1987). Sex differences in addict careers. 2. Becoming addicted. Am. J. Drug Alcohol Abuse 13:59–71.
Bachman, J. G., Freedman-Doan, P., O’Malley, P. M., Johnston, L. D., and Segal, D. R. (1999). Changing patterns of drug use among US military recruits before and after enlistment. Am. J. Public Health 89:672–677.
Bachman, J. G., Johnston, L. D., and O’Malley, P. M. (1990). Explaining the recent decline in cocaine use among young adults: further evidence that perceived risks and disapproval lead to reduced drug use. J. Health Soc. Behav. 31:173–184.
Bachman, J. G., O’Malley, P. M., and Johnston, L. D. (1984). Drug use among young adults: the impacts of role status and social environment. J. Pers. Soc. Psychol. 47:629–645.
Bailey, P. (1916). The heroin habit. The New Republic. April 22, 1916. 6:314–316.
Battjes, R. J., Pickens, R. W., and Amsel, Z. (1991). HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities. J. Acquir. Immune. Defic. Syndr. 4:1148–1154.
Belenko, S.R. (ed.). (2000). Drugs and drug policy in America: A documentary history. Westport, CT: Greedwood Press.
Berkman, L. F. and Kawachi, I. (2000). Social Epidemiology. Oxford University Press, New York.
Beyers, J. M., Toumbourou, J. W., Catalano, R. F., Arthur, M. W., and Hawkins, J. D. (2004). A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia. J. Adolesc. Health 35:3–16.
Bo, O., Haftner, J. F., Langard, O., Trumpy, J. H., Bredesen, J. E., and Lunden, P. K. M. (1975). Ethanol and diazepam as causative agents in road traffic accidents. In: Israelstan, S., and Lambert S. (eds.), Alcohol, drugs, and traffic safety. Addiction Research Foundation, Toronto, pp 62–81.
Boardman, J. D., Finch, B. K., Ellison, C. G., Williams, D. R., and Jackson, J. S. (2001). Neighborhood disadvantage, stress, and drug use among adults. J. Health Soc. Behav. 42:151–165.
Booth, R. E., Watters, J. K., and Chitwood, D. D. (1993). HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am. J. Public Health 83:1144–1148.
Bretteville-Jensen, A. L. (1999). Gender, heroin consumption and economic behavior. Health Econ. 8:379–389.
Broadhead, R. S., van Hulst, Y., and Heckathorn, D. D. (1999). The impact of a needle exchange’s closure. Public Health Rep. 114:439–447.
Buning, E. C. (1991). Effects of Amsterdam needle and syringe exchange. Int. J. Addict. 26:1303–1311.
Calsyn, D. A., Saxon, A. J., Freeman, G., and Whittaker, S. (1991). Needle-use practices among intravenous drug users in an area where needle purchase is legal. AIDS 5:187–193.
Centers for Disease Control and Prevention, (2002), Division of HIV/AIDS Prevention, Washington, D.C., (September 28, 2004); http://www.cdc.gov/hiv/pubs/facts.htm.
Chaisson, R. E., Moss, A. R., Onishi, R., Osmond, D., and Carlson, J. R. (1987). Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am. J. Public Health 77:169–172.
Chamberlain, J. M., and Klein, B. L. (1994). A comprehensive review of naloxone for the emergency physician. Am. J. Emerg. Med. 12:650–660.
Cherubin, C., McCusker, J., Baden, M., Kavaler, F., and Amsel, Z. (1972). Epidemiology of death in narcotic addicts. Am. J. Epidemiol. 96:11–22.
Cherubin, C. E. (1967). The medical sequelae of narcotic addiction. Ann. Intern. Med. 67:23–33.
Cherubin, C. E., and Sapira, J. D. (1993). The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann. Intern. Med. 119: 1017–1028.
Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., and Tardiff, K. (2002a). Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990–1998. Addiction 98(6):711.
Cohen, D., Spear, S., Scribner, R., Kissinger, P., Mason, K., and Wildgen, J. (2000). “Broken windows” and the risk of gonorrhea. Am. J. Public Health 90:230–236.
Colon, H.M., Robles, R.R., Deren, S., Sahai, H., Finlinson, H.A., Andia, J., Cruz, M.A., Kang, S.Y., and Oliver-Velez, D.(2001). Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. J. Acquir. Immune Defic. Syndr. 27:405–413.
Conry-Cantilena, C., Van Raden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J.W., Kaslow, R., Ness, P., and Alter, H.J. (1996). Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N. Engl. J. Med. 334:1691–1696.
Cook, R. L., Royce, R. A., Thomas, J. C., and Hanusa, B. H. (1999). What’s driving an epidemic? The spread of syphilis along an interstate highway in rural North Carolina. Am. J. Public Health 89:369–373.
Cook, S., Moeschler, O., Michaud, K., and Yersin, B. (1998). Acute opiate overdose: characteristics of 190 consecutive cases. Addiction 93:1559–1565.
Cretzmeyer, M., Sarrazin, M. V., Huber, D. L., Block, R. I., and Hall, J. A. (2003). Treatment of methamphetamine abuse: research findings and clinical directions. J. Subst. Abuse Treat. 24:267–277.
Cronk, C. E., and Sarvela, P. D. (1997). Alcohol, tobacco, and other drug use among rural/small town and urban youth: a secondary analysis of the monitoring the future data set. Am. J. Public Health 87:760–764.
Crum, R. M., Lillie-Blanton, M., and Anthony, J. C. (1996). Neighborhood environment and opportunity to use cocaine and other drugs in late childhood and early adolescence. Drug Alcohol Depend. 43:155–161.
Darke, S., Ross, J., and Hall, W. (1996a). Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose. Addiction 91:405–411.
Darke, S., Ross, J., and Hall, W. (1996b). Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction 91:413–417.
Darke, S., and Zador, D. (1996). Fatal heroin ‘overdose’: a review. Addiction 91:1765–1772.
Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R., and Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J. Urban Health 80:261–273.
Degenhardt, L., Lynskey, M., and Hall, W. (2000). Cohort trends in the age of initiation of drug use in Australia. Aust. N. Z. J. Public Health 24:421–426.
Deren, S., Robles, R., Andia, J., Colon, H. M., Kang, S. Y., and Perlis, T. (2001). Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992–1999. J. Acquir. Immune Defic. Syndr. 26:164–169.
Des Jarlais, D.C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., Rockwell, R., Edwards, V., Friedman, S.R., Monterroso, E., Williams, I., and Garfein, R.S. (2003). Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157:467–471.
Des Jarlais, D.C., Marmor, M., Paone, D., Titus, S., Shi, Q., Perlis, T., Jose, B., and Friedman, S.R. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 348:987–991.
Des Jarlais, D. C., McKnight, C., and Milliken, J. (2004). Public funding of US syringe exchange programs. J. Urban Health 81:118–121.
Des Jarlais, D.C., Perlis, T., Friedman, S.R., Deren, S., Chapman, T., Sotheran, J.L., Tortu, S., Beardsley, M., Paone, D., Torian, L.V., Beatrice, S.T., DeBernardo, E., Monterroso, E., and Marmor, M. (1998). Declining seroprevalence in a very large HIV epidemic: injecting drug users in New York City, 1991 to 1996. Am. J. Public Health 88:1801–1806.
Des Jarlais, D.C., Diaz, T., Perlis, T., Vlahov, D., Maslow, C., Latka, M., Rockwell, R., Edwards, V., Friedman, S.R., Monterroso, E., Williams, I., and Garfein, R.S. (2003). Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157:467–471.
Dettmer, K., Saunders, B., and Strang, J. (2001). Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 322:895–896.
Diaz, T., Des Jarlais, D.C., Vlahov, D., Perlis, T.E., Edwards, V., Friedman, S.R, Rockwell, R., Hoover, D., Williams, I.T., and Monterroso, E.R. (2001). Factors associated with prevalence hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. Am. J. Public Health 91:23–30.
Dolan, K., Kimber, J., Fry, C., Fitzgerald, J., McDonald, D., and Trautmann, F. (2000). Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 19:337–346.
Dolan, K., and Wodak, A. (1996), Switzerland, (September 28, 2004); http://www.lindesmith.org/library/dolan2.cfm
Drucker, E. (2002). Population impact of mass incarceration under New York’s Rockefeller drug laws: an analysis of years of life lost. J. Urban Health 79:434–435.
Drugs approved for opiate dependence (2003). FDA Consum. 37:6.
Duncan, S. C., Duncan, T. E., and Strycker, L. A. (2002). A multilevel analysis of neighborhood context and youth alcohol and drug problems. Prev. Sci. 3:125–133.
Edeh, J., and Spalding, P. (2000). Screening for HIV, HBV and HCV markers among drug users in treatment in rural south-east England. J. Public Health Med. 22:531–539.
Edlin, B.R., Irwin, K.L., Faruque, S., McCoy, C.B., Word, C., Serrano, Y., Inciardi, J.A., Bowser, B.P., Schilling, R.F., and Holmberg, S.D. (1994a). Intersecting epidemics-crack cocaine use and HIV infection among inner-city young adults. Multicenter Crack Cocaine and HIV Infection Study Team. N. Engl. J. Med. 331:1422–1427.
Ellickson, P. L., and Morton, S. C. (1999). Identifying adolescents at risk for hard drug use: racial/ethnic variations. J. Adolesc. Health 25: 82–395.
Ennett, S. T., Tobler, N. S., Ringwalt, C. L., and Flewelling, R. L. (1994). How effective is drug abuse resistance education? A meta-analysis of Project DARE outcome evaluations. Am. J. Public Health 84:1394–1401.
Ensminger, M. E., Anthony, J. C., and McCord, J. (1997b). The inner city and drug use: initial findings from an epidemiological study. Drug Alcohol Depend. 48:175–184.
Epstein, J. A., Botvin, G. J., Griffin, K. W., and Diaz, T. (1999). Role of ethnicity and gender in polydrug use among a longitudinal sample of inner-city adolescents. J. Alcohol Drug Education 45:1–12.
FDA Consumer. (2003). Drugs approved for opiate dependence. FDA Consumer 37(1):6.
Federal Registry. (2003). Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medication. Interim final rule. Federal Registry 68(99):27937–27939.
Fischer, B. (1995). Drugs, communities, and “harm reduction” in Germany: the new relevance of “public health” principles in local responses. J. Public Health Policy 16:389–411.
Flom, P.L., Friedman, S.R., Kottiri, B.J., Neaigus, A., Curtis, R., Des Jarlais, D.C., Sandoval, M., and Zenilman, J.M. (2001). Stigmatized drug use, sexual partner concurrency, and other sex risk network and behavior characteristics of 18-to 24-year-old youth in a high-risk neighborhood. Sex. Transm. Dis. 28:598–607.
Freudenberg, N., Vlahov, D., and Galea, S. (2005). Beyond urban penalty and urban sprawl: Back to living conditions as the focus of urban health. J. Communinty Health 30(1): 1–11.
Frischer, M., Anderson, S., Hickman, M., and Heatlie, H. (2002). Diffusion of drug misuse in Scotland: Findings from the 1993 and 1996 Scottish Crime Surveys. Addiction Research & Theory 10:83–95.
Fuller, C. M., Borrell, L. N., Galea, S., and Vlahov D. (2002). The effect of race, neighborhood, and social network on adolescent initiation of injection drug use among recont-onset injection drug users in Baltimore, Maryland. Paper presented at the 2002 AIDS Conference, Barcelona Spain, 7–12 July 2002.
Fuller, C. M., Vlahov, D., Arria, A. M., Ompad, D. C., Garfein, R. S., and Strathdee, S. A. (2001). Factors associated with adolescent initiation of injection drug use. Public Health Rep. 116:136–145.
Fuller, C. M., Vlahov, D., Ompad, D. C., Shah, N., Arria, A., and Strathdee, S. A. (2002). High-risk behaviors associated with transition from illicit non-injection to injection drug use among adolescent and young adult drug users: a case-control study. Drug Alcohol Depend. 66:189–198.
Fullilove, R. E., Fullilove, M. T., Bowser, B. P., and Gross, S. A. (1990). Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, Calif. JAMA. 263:851–855.
Furst, R. T., Herrmann, C., Leung, R., Galea, J., and Hunt, K. (2004). Heroin diffusion in the mid-Hudson region of New York State. Addiction 99:431–441.
Galea, S., Ahern, J., Tardiff, K., Leon, A. C., Coffin, P. O., Derr, K., and Vlahov, D. (2003). Racial/ethnic disparities in overdose mortality trends in New York City, 1990–1998. J. Urban Health 80:201–211.
Galea, S., Ahern, J., and Vlahov, D. (2003). Contextual determinants of drug use risk behavior: a theoretic framework. J. Urban Health 80:iii50–iii58.
Galea, S., Ahern, J., Vlahov, D., Coffin, P. O., Fuller, C., Leon, A. C., and Tardiff, K. (2003). Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend. 70:139–148.
Galea, S., Ahern, J., Vlahov, D., Coffin, P. O., Leon, A. C., and Tardiff, K. (2003b). Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug Alcohol Depend. 70(2):139–48.
Galea, S., Nandi, A., and Vlahov, D. (2004). The social epidemiology of substance use. Epidemiol Rev. 26:36–52.
Galea, S., and Vlahov, D. (2005). Urban Health: Evidence, Challenges, and Directions. Annu. Rev. Public Health 26; 341–365.
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., and Nelson, K. E. (1996). Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 86:655–661.
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium (1999). J. Viral Hepat. 6:35–47.
Goetz, E. G. (1996). The US war on drugs as urban policy. J.Urban Regional Res. 20:539–549.
Goldstein, S. T., Alter, M. J., Williams, I. T., Moyer, L. A., Judson, F. N., Mottram, K. Fleenor, M., Ryder, P.L., and Margolis, H.S. (2002). Incidence and risk factors for acute hepatitis B in the United States, 1982–1998: implications for vaccination programs. J. Infect. Dis. 185:713–719.
Golub, A. and Johnson, B. D. (2001). Variation in youthful risks of progression from alcohol and tobacco to marijuana and to hard drugs across generations. Am. J. Public Health 91:225–232.
Gordon, D. R. (1994). The return of the dangerous classes: Drug prohibition and policy politics. W.W. Norton & Co., New York.
Gossop, M., Griffiths, P., and Strang, J. (1994). Sex differences in patterns of drug taking behaviour. A study at a London community drug team. Br. J. Psychiatry 164:101–104.
Grandjean, E., Graf, P., Lauber, A., Meier, H., and Muller, R. (1976). Survey on the effects of noise around three civil airports in Switzerland. In: Kerlin, R. (ed.), Internoise’ 76. Institute of Noise Control Engineers, Washington D.C., pp 85–90.
Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., Fehrs, L. J., and Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers-Connecticut, 1992—1993. J Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10:82–89.
Gyarmathy, V. A., Neaigus, A., Miller, M., Friedman, S. R., and Des, J. (2002b). Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir. Immune. Defic. Syndr. 30:448–456.
Harlow, K. C. (1990). Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976–87. Public Health Rep. 105:455–462.
Haw, S., and Higgins, K. (1998). A comparison of the prevalence of HIV infection and injecting risk behaviour in urban and rural samples in Scotland. Addiction 93: 855–863.
Hearn, W. L., Rose, S., Wagner, J., Ciarleglio, A., and Mash, D. C. (1991). Cocaethylene is more potent than cocaine in mediating lethality. Pharmacol. Biochem. Behav. 39:531–533.
Hepatitis B vaccination for injection drug users-Pierce County, Washington, 2000 (2001). MMWR. 50, 388–90, 399.
Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am. J. Public Health 86:642–654.
Hser, Y. I., Chou, C. P., Hoffman, V., and Anglin, M. D. (1999). Cocaine use and high-risk sexual behavior among STD clinic patients. Sex. Transm. Dis. 26:82–86.
Hughes, P. H., Barker, N. W., Crawford, G. A., and Jaffe, J. H. (1972). The natural history of a heroin epidemic. Am. J. Public Health 62:995–1001.
Hunt, L. G., and Chambers, C. D. (1976). The heroin epidemics: a study of heroin use in the United States, 1965–1975. Spectrum Publications, New York, New York.
Hurley, S. F., Jolley, D. J., and Kaldor, J. M. (1997). Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet 349:1797–1800.
Hwang, L. Y., Ross, M. W., Zack, C., Bull, L., Rickman, K., and Holleman, M. (2000a). Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clin. Infect. Dis. 31:920–926.
Jaffe, J. H., and O’Keeffe, C. (2003). From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States. Drug Alcohol Depend. 70:S3–S11.
Johnson, R. A., and Gerstein, D. R. (2000). Age, period, and cohort effects in marijuana and alcohol incidence: United States females and males, 1961–1990. Subst. Use Misuse. 35:925–948.
Johnston, L. D., O’Malley, P. M., Bachman, J. G., and Schulenberg, J. E. (2004). Monitoring the Future national survey results on drug use, 1975–2003. Volume I: Secondary school students Rep. No. NIH Publication No. 04-5507. National Institute on Drug Abuse, Bethesda, MD.
Kandel, D. (1975). Stages in adolescent involvement in drug abuse. Science 190:912–914.
Kandel, D. B., Yamaguchi, K., and Chen, K. (1992). Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. J. Stud. Alcohol 53:447–457.
Kane, M. (1995). Global programme for control of hepatitis B infection. Vaccine 1:S47–9.
Kaplan, E. H., and Heimer, R. (1995). HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 10:175–176.
Kaplan, G. A., Everson, S. A., and Lynch, J.W. (2000). The contribution of social and behavioral research to an understanding of the distribution of disease: A multi-level approach. In: Smedley B.D., and Syme., S.L. (eds.), Promoting health: Intervention strategies from social and behavioral research. National Academy Press, Washington D.C., pp 37–80.
Kaplan, G. A., Pamuk, E. R., Lynch, J. W., Cohen, R. D., and Balfour, J. L. (1996). Inequality in income and mortality in the United States: analysis of mortality and potential pathways. BMJ. 312:999–1003.
Karapetyan, A. F., Sokolovsky, Y. V., Araviyskaya, E. R., Zvartau, E. E., Ostrovsky, D. V., and Hagan, H. (2002). Syphilis among intravenous drug-using population: epidemiological situation in St Petersburg, Russia. Int. J. STD AIDS. 13: 618–623.
Karlsson, G., and Romelsjo, A. (1997). A longitudinal study of social, psychological and behavioural factors associated with drunken driving and public drunkenness. Addiction 92:447–457.
Kawachi, I., and Berkman, L. (2000). Social cohesion, social capital and health. In: Berkman L., and I. Kawachi, I. (eds.), Social epidemiology. Oxford Unviersity Press, New York, pp 174–190.
Kawachi, I., and Kennedy, B. P. (1997). Health and social cohesion: why care about income inequality? BMJ. 314:1037–1040.
Kawachi, I., Kennedy, B. P., Lochner, K., and Prothrow-Stith, D. (1997). Social capital, income inequality, and mortality. Am. J. Public Health 87:1491–1498.
Kennedy, B. P., Kawachi, I., Prothrow-Stith, D., Lochner, K., and Gupta, V. (1998). Social capital, income inequality, and firearm violent crime. Soc. Sci. Med. 47:7–17.
Keyes, L. C. (1992). Strategies and saints: Fighting drugs in subsidized housing. The Urban Institute Press, Washington, D.C.
Kintz, P., Brenneisen, R., Bundeli, P., and Mangin, P. (1997). Sweat testing for heroin and metabolites in a heroin maintenance program. Clin.Chem. 43:736–739.
Kleber, H. D. (1994). Our current approach to drug abuse-progress, problems, proposals. N. Engl. J. Med. 330:361–365.
Knipschild, P., and Oudshoorn, N. (1977). VII. Medical effects of aircraft noise: drug survey. Int. Arch. Occup. Environ. Health 40:197–200.
Koblin, B. A., Factor, S. H., Wu, Y., and Vlahov, D. (2003). Hepatitis C virus infection among non-injecting drug users in New York City. J. Med. Virol. 70:387–390.
Kottiri, B. J., Friedman, S. R., Neaigus, A., Curtis, R., and Des, J. (2002). Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J. Acquir. Immune. Defic. Syndr. 30:95–104.
Kral, A. H., Bluthenthal, R. N., Booth, R. E., and Watters, J. K. (1998b). HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am. J Public Health 88:108–113.
Kral, A.H., Bluthenthal, R.N., Booth, R.E., and Watters, J.K. (1998a) HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am. J. Public Health 88(1):108–113.
Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 357:1397–1401.
Kral, A. H., Lorvick, J., and Edlin, B. R. (2000). Sex-and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. J. Acquir. Immune. Defic. Syndr. 24:162–167.
Kral, A. H., Lorvick, J., Gee, L., Bacchetti, P., Rawal, B., Busch, M., and Edlin, B.R. (2003). Trends in human immunodeficiency virus seroincidence among street-recruited injection drug users in San Francisco, 1987–1998. Am. J. Epidemiol. 157:915–922.
Kumar, R., O’Malley, P. M., Johnston, L. D., Schulenberg, J. E., and Bachman, J. G. (2002). Effects of school-level norms on student substance use. Prev. Sci. 3:105–124.
Lange, W. R., Snyder, F. R., Lozovsky, D., Kaistha, V., Kaczaniuk, M. A., and Jaffe, J. H. (1988). Geographic distribution of human immunodeficiency virus markers in parenteral drug abusers. Am. J. Public Health 78:443–446.
Latkin, C. A., Forman, V., Knowlton, A., and Sherman, S. (2003). Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users. Soc. Sci. Med. 56:465–476.
Lerner, M., and Nurco, D. N. (1970). Drug abuse deaths in Baltimore, 1951–1966. Int. J. Addict.. 5:693–716.
Leukefeld, C. G., Narevic, E., Hiller, M. L., Staton, M., Logan, T. K., Gillespie, W., Webster, J.M., Garrity, T.F., and Purvis, R. (2002). Alcohol and drug use among rural and urban incarcerated substance abusers. Int. J. Offender. Ther. Comp. Criminol. 46: 715–728.
Levy, S. J., and Pierce, J. P. (1990). Predictors of marijuana use and uptake among teenagers in Sydney, Australia. Int. J. Addict. 25:1179–1193.
Lillie-Blanton, M., Parsons, P. E., Gayle, H., and Dievler, A. (1996). Racial differences in health: not just black and white, but shades of gray. Annu. Rev. Public Health 17:411–48.
Lindenberg, C. S., Strickland, O., Solorzano, R., Galvis, C., Dreher, M., and Darrow, V. C. (1999). Correlates of alcohol and drug use among low-income Hispanic immigrant childbearing women living in the USA. Int. J. Nurs. Stud.36:3–11.
Ling, W., and Smith, D. (2002). Buprenorphine: blending practice and research. J. Subst. Abuse Treat. 23:87–92.
Logan, D. G. (1973). Heroin maintenance clinics: does the “British System” have answers for U.S. addiction treatment shortcomings? Proc. Natl. Conf. Methadone. Treat. 1:579–585.
Logan, T. K., and Leukefeld, C. (2000a). Sexual and drug use behaviors among female crack users: a multi-site sample. Drug Alcohol Depend.58:237–245.
Logan, T. K., and Leukefeld, C. (2000b). Sexual and drug use behaviors among female crack users: a multi-site sample. Drug Alcohol Depend. 58:237–245.
Lora-Tamayo, C., Tena, T., and Rodriguez, A. (1994). Cocaine-related deaths. J. Chromatogr. A. 674:217–224.
Lynam, D. R., Milich, R., Zimmerman, R., Novak, S. P., Logan, T. K., Martin, C., Leukefeld, C., and Clayton R. (1999). Project DARE: no effects at 10-year follow-up. J. Consult. Clin. Psychol. 67:590–593.
Macalino, G.E., Springer, K.W., Rahman, Z.S., Vlahov, D., and Jones, T.S. (1998). Community-based programs for safe disposal and used needles and syringes. J. Acquir. Immune, Defic. Syndr. Hum. Retrovirol. 18(Suppl 1):S111–9.
Madianos, M. G., Gefou-Madianou, D., Richardson, C., and Stefanis, C. N. (1995). Factors affecting illicit and licit drug use among adolescents and young adults in Greece. Acta. Psychiatr. Scand. 91:258–264.
Manning, F. J., and Ingraham, L. H. (1983). Drug “overdoses” among U.S. soldiers in Europe, 1978–1979. I. Demographics and toxicology. Int. J. Addict. 18:89–98.
Marczynski, K. S., Welte, J. W., Marshall, J. R., and Ferby, E. N. (1999). Prevalence and determinants of alcohol-related problems. Am. J. Drug Alcohol Abuse 25:715–730.
Marzuk, P. M., Tardiff, K., Leon, A. C., Hirsch, C. S., Stajic, M., Portera, L., and Hartwell, N. (1997a). Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: an ecological study. Am. J. Drug Alcohol Abuse 23:221–228.
McGinnis, J. M., and Foege, W. H. (1999). Mortality and morbidity attributable to use of addictive substances in the United States. Proc. Assoc. Am. Physicians 111:109–118.
McMahon, J. M., Simm, M., Milano, D., and Clatts, M. (2004). Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann. Clin. Microbiol. Antimicrob. 3:6.
McMahon, J. M., and Tortu, S. (2003). A potential hidden source of hepatitis C infection among noninjecting drug users. J. Psychoactive Drugs 35:455–460.
Metsch, L. R., and McCoy, C. B. (1999). Drug treatment experiences: rural and urban comparisons. Subst. Use. Misuse. 34:763–784.
Molinari, S. P., Cooper, J. R., and Czechowicz, D. J. (1994). Federal regulation of clinical practice in narcotic addiction treatment: purpose, status, and alternatives. J. Law Med. Ethics 22:231–239.
Molitor, F., Truax, S. R., Ruiz, J. D., and Sun, R. K. (1998). Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users. West J. Med. 168:93–97.
Montoya, I. D., and Atkinson, J. S. (1996). Determinants of HIV seroprevalence rates among sites participating in a community-based study of drug users. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 13:169–176.
Morral, A. R., McCaffrey, D. F., and Paddock, S. M. (2002). Reassessing the marijuana gateway effect. Addiction 97:1493–1504.
Morral, A. R., McCafrey, D. F., and Paddock, S. M. (2002). Evidence does not favor marijuana gateway effects over a common-factor interpretation of drug use initiation: responses to Anthony, Kenkel & Mathios and Lynskey. Addiction 97:1509–1510.
Mueser, K. T., Essock, S. M., Drake, R. E., Wolfe, R. S., and Frisman, L. (2001). Rural and urban differences in patients with a dual diagnosis. Schizophr. Res. 48:93–107.
Murrill, C. S., Weeks, H., Castrucci, B. C., Weinstock, H. S., Bell, B. P., Spruill, C., and Gwinn, M. (2002). Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am. J. Public Health 92:385–387.
Murrill, C.S., Prevots, D.R., Miller, M.S., Linley, L.A., Royalty J.E., and Gwinn, M. (2001). Incidence of HIV among injection drug users entering drug treatment programs in four U.S. cities. J. Urban Health 78(1):152–61.
National Household Survey on Drug Abuse, 1997. (11-28-2002). Substance Abuse and Mental Health Service Administration.
National Institute on Drug Abuse. (1997). Rural substance abuse: State of knowledge and Issues. vols. 168. National Institutes of Health, Rockville, MD.
Neaigus, A., Friedman, S. R., Jose, B., Goldstein, M. F., Curtis, R., Ildefonso, G., and Des Jarlais, D.C. (1996). High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors. J. Acquir. Immune. Defic. Syndr. Hum. Retrovirol. 11:499–509.
Neaigus, A., Miller, M., Friedman, S. R., and Des, J. (2001). Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J. Infect. Dis. 184:359–363.
Newcomb, M. D., and Bentler, P. M. (1986). Cocaine use among young adults. Adv. Alcohol. Subst. Abuse 6:73–96.
Novick, D. M., Trigg, H. L., Des, J., Friedman, S. R., Vlahov, D., and Kreek, M. J. (1989). Cocaine injection and ethnicity in parenteral drug users during the early years of the human immunodeficiency virus (HIV) epidemic in New York City. J. Med. Virol. 29:181–185.
Office of Applied Studies, Substance Abuse and Mental Health Services Administration. (1998). Preliminary results from the 1997 National Household Survey on Drug Abuse, DHHS Publication No. SMA 98-3251. Department of Health and Human Services, Rockville, MD.
Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. (2003b). Interim final rule. Fed. Regist. 68:27937–27939.
Othieno, C. J., Kathuku, D. M., and Ndetei, D. M. (2000). Substance abuse in outpatients attending rural and urban health centres in Kenya. East Afr. Med. J. 77:592–595.
Paone, D., Des, J., Gangloff, R., Milliken, J., and Friedman, S. R. (1995). Syringe exchange: HIV prevention, key findings, and future directions. Int. J. Addict.30:1647–1683.
Parry, A. (1992). Taking heroin maintenance seriously: the politics of tolerance. Lancet 339:350–351.
Perneger, T. V., Giner, F., del, R. M., and Mino, A. (1998). Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ. 317:13–18.
Perucci, C. A., Davoli, M., Rapiti, E., Abeni, D. D., and Forastiere, F. (1991). Mortality of intravenous drug users in Rome: a cohort study. Am. J. Public Health 81:1307–1310.
Powis, B., Griffiths, P., Gossop, M., and Strang, J. (1996). The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst. Use Misuse. 31:529–543.
Quaglio, G., Lugoboni, F., Pajusco, B., Sarti, M., Talamini, G., Lechi, A., Mezzelani, P., and Des Jarlais, D.C. (2003). Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy. Clin. Infect. Dis. 37:33–40.
Read, N. (2003). Canada’s first safe-injection site opens: Mirrored booths, ‘chill out’ room featured in controversial, taxpayer-funded centre. Ottawa Citizen September 16, 2003.
Renwick, N., Dukers, N. H., Weverling, G. J., Sheldon, J. A., Schulz, T. F., Prins, M. Coutinho, R.A., and Goudsmit, J. (2002). Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985–1996. J. Infect. Dis. 185:1808–1812.
Rhodes, T., Judd, A., Mikhailova, L., Sarang, A., Khutorskoy, M., Platt, L., Lowndes, C.M., and Renton, A. (2004). Injecting equipment sharing among injecting drug users in Togliatti City, Russian Federation: maximizing the protective effects of syringe distribution. J. Acquir. Immune. Defic. Syndr. 35:293–300.
Rhodes, T., Mikhailova, L., Sarang, A., Lowndes, C. M., Rylkov, A., Khutorskoy, M., and Renton A. (2003). Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc. Sci. Med. 57:39–54.
Rockefeller, N. G. (1973). Annual message to the New York State legislature. Ref Type: Unpublished Work.
Rockwell, R., Deren, S., Goldstein, M. F., Friedman, S. R., and Des, J. (2002). Trends in the AIDS epidemic among New York City’s injection drug users: localized or citywide? J. Urban Health 79:136–146.
Ross, M. W., Hwang, L. Y., Zack, C., Bull, L., and Williams, M. L. (2002). Sexual risk behaviours and STIs in drug abuse treatment populations whose drug of choice is crack cocaine. Int. J. STD AIDS 13:769–774.
Roy, E., Haley, N., Leclerc, P., Cédras, L., Blais, L., and Boivin, J. (2002). Drug injection among street youth: Predictors of initiation. J. Urban Health 80:92–105.
Roy, E., Haley, N., Leclerc, P., Cedras, L., Blais, L., and Boivin, J. F. (2003). Drug injection among street youths in Montreal: predictors of initiation. J. Urban Health 80:92–105.
Russell, S. (2002). Pilot program for heroin addicts saved lives, doctors say; Emergency antidote given for overdoses. San Francisco Chronicle December 3, 2002.
Sanchez, J., Comerford, M., Chitwood, D. D., Fernandez, M. I., and McCoy, C. B. (2002). High risk sexual behaviours among heroin sniffers who have no history of injection drug use: implications for HIV risk reduction. AIDS Care 14:391–398.
Sarkar, K., Panda, S., Das, N., and Sarkar, S. (1997). Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India. Indian J. Public Health 41:49–51.
Schmid, H. (2001). Cannabis use in Switzerland: The role of attribution of drug use to friends, urbanization and repression. Swiss J. Psychol. 60:99–107.
Schoenbaum, E. E., Hartel, D., Selwyn, P. A., Klein, R. S., Davenny, K., Rogers, M., and Feiner, C., and Friedland, G. (1989). Risk factors for human immunodeficiency virus infection in intravenous drug users. N. Engl. J. Med. 321:874–879.
Scribner, R., Cohen, D., Kaplan, S., and Allen, S. H. (1999). Alcohol availability and homicide in New Orleans: conceptual considerations for small area analysis of the effect of alcohol outlet density. J. Stud. Alcohol. 60:310–316.
Seal, K. H., Kral, A. H., Gee, L., Moore, L. D., Bluthenthal, R. N., Lorvick, J., and Edlin, B.R. (2001). Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998–1999. Am. J. Public Health 91:1842–1846.
Sergeev, B., Karpets, A., Sarang, A., and Tikhonov, M. (2003). Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J. Urban Health 80:212–219.
Stark, K., Bienzle, U., Vonk, R., and Guggenmoos-Holzmann, I. (1997). History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int. J. Epidemiol. 26:1359–1366.
Storr, C. L., Arria, A. M., Workman, Z. R., and Anthony, J. C. (2004). Neighborhood environment and opportunity to try methamphetamine (“ice”) and marijuana: evidence from Guam in the Western Pacific region of Micronesia. Subst. Use. Misuse. 39:253–276.
Substance Abuse and Mental Health Service Administration & Office of Applied Studies (2004). Treatment Episode Data Set (TEDS) 1992–2002: National admissions to substance abuse treatment services Report No. DHHS Publication No. SMA 04-3965. Department of Health and Human Services, Rockville, MD.
Substance Abuse and Mental Health Service Administration & Office of Applied Studies (2003). Emergency Department Trends From DAWN: Final Estimates 1995–2002. Report No. DAWN Series D-24, DHHS Publication No. SMA 03-3780. Rockville, MD.
Substance Abuse and Mental Health Services Administration, 2001, National Household Survey on Drug Abuse, 1988–2000, (September 28, 2004); http://www.oas.samhsa.gov/nhsda/2k1nhsda/vol1/toc.htm
Substance Abuse and Mental Health Services Administration & Office of Applied Studies (2003a). National Survey on Drug Use and Health, 2002 Rockville, MD.
Substance Abuse and Mental Health Services Administration & Office of Applied Studies (2003b). Results from the 2002 National Survey on Drug Use and Health: National Findings Report No. NHSDA Series H-22, DHHS Publication No. SMA 03-3836. Rockville, MD.
Substance Abuse and Mental Health Services Administration & Office of Applied Studies (2004). Results from the 2003 National Survey on Drug Use and Health: National Findings Report No. NHSDA Series H-25, DHHS Publication No. SMA 04-3964. Rockville, MD.
Syme, L. S., and Balfour, J. L. (1998). Social determinants of disease. In: R.B. Wallace, R.B., and Doebbeling, B.H. (eds.), Public Health and Preventive Medicine (12 ed.). Appleton and Lange, Stanford, CT.
Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., and Monterroso, E. R. (2000). Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J. Infect. Dis. 182:1588–1594.
Tobin, K. E., and Latkin, C. A. (2003). The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. J. Urban Health 80: 220–229.
Tortu, S., McMahon, J. M., Pouget, E. R., and Hamid, R. (2004). Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst. Use Misuse. 39:211–224.
Tortu, S., Neaigus, A., McMahon, J., and Hagen, D. (2001). Hepatitis C among noninjecting drug users: a report. Subst. Use Misuse. 36:523–534.
U.S. Census Bureau. (2000). U.S. Census 2000. U.S. Department of Commerce, Economic and Statistics Administration, Washington D.C.
United Nations & Office on Drugs and Crime (2003). Global illicit drug trends 2003. United Nations, New York.
Van Etten, M. L., and Anthony, J. C. (2001). Male-female differences in transitions from first drug opportunity to first use: searching for subgroup variation by age, race, region, and urban status. J. Womens Health Gend. Based. Med. 10:797–804.
Van Etten, M. L., Neumark, Y. D., and Anthony, J. C. (1997). Initial opportunity to use marijuana and the transition to first use: United States, 1979–1994. Drug Alcohol Depend.49:1–7.
Van Haastrecht, H. J., van Ameijden, E. J., Van den Hoek, J. A., Mientjes, G. H., Bax, J. S., and Coutinho, R. A. (1996). Predictors of mortality in the Amsterdam cohort of human immunodeficiency virus (HIV)-positive and HIV-negative drug users. Am. J. Epidemiol. 143: 380–391.
Villano, S. A., Vlahov, D., Nelson, K. E., Lyles, C. M., Cohn, S., and Thomas, D. L. (1997). Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J. Clin. Microbiol. 35:3274–3277.
Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D. Solomon, L., and Polk, B.F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res. Monogr. 109: 75–100.
Vlahov, D., and Junge, B. (1998). The role of needle exchange programs in HIV prevention. Public Health Rep. 113Suppl 1:75–80.
Vlahov, D., Munoz, A., Anthony, J. C., Cohn, S., Celentano, D. D., and Nelson, K. E. (1990). Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am. J. Epidemiol. 132:847–856.
Vlahov, D., Wang, C. L., Galai, N., Bareta, J., Mehta, S. H., Strathdee, S. A., and Nelson, K.E.(2004). Mortality risk among new onset injection drug users. Addiction 99:946–954.
von, S. K., Lieb, R., Pfister, H., Hofler, M., and Wittchen, H. U. (2002). What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults. Drug Alcohol Depend. 68:49–64.
Wagner, F., Diaz, D. B., Lopez, A. L., Collado, M. E., and Aldaz, E. (2002). Social cohesion, cultural identity, and drug use in Mexican rural communities. Subst. Use Misuse. 37:715–747.
Wagner, F. A., and Anthony, J. C. (2002). Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am. J. Epidemiol. 155:918–925.
Wallace, J. M., Jr. (1999). The social ecology of addiction: race, risk, and resilience. Pediatrics 103:1122–1127.
Wallace, J. M., Jr., Bachman, J. G., O’Malley, P. M., Johnston, L. D., Schulenberg, J. E., and Cooper, S. M. (2002). Tobacco, alcohol, and illicit drug use: racial and ethnic differences among U.S. high school seniors, 1976–2000. Public Health Rep. 117(Suppl 1):S67–S75.
Wallace, R., Fullilove, M. T., and Wallace, D. (1992). Family systems and deurbanization: Implications for substance abuse. In: Lowinson, J.H., Ruiz, P., and Millman, R.B. (eds.), Substance abuse: A comprehensvie textbook (2nd ed.). Williams and Wilkins, Baltimore, MD, pp 944–955.
Warner, B. D., and Leukefeld, C. G. (2001). Rural-urban differences in substance use and treatment utilization among prisoners. Am. J. Drug Alcohol Abuse 27:265–280.
Warner, E. A., Kosten, T. R., and O’Connor, P. G. (1997). Pharmacotherapy for opioid and cocaine abuse. Med. Clin. North Am. 81:909–925.
Warner, L. A., Kessler, R. C., Hughes, M., Anthony, J. C., and Nelson, C. B. (1995). Prevalence and correlates of drug use and dependence in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 52:219–229.
Watters, J. K., Estilo, M. J., Kral, A. H., and Lorvick, J. J. (1994). HIV infection among female injection-drug users recruited in community settings. Sex. Transm. Dis. 21:321–328.
Wilcox, H. C., Wagner, F. A., and Anthony, J. C. (2002). Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use. Drug Alcohol Depend. 66:127–135.
Wood, E., Spittal, P. M., Small, W., Kerr, T., Li, K., Hogg, R. S., Tyndall, M.W., Montaner, J.S.G., and Schechter, M.T. (2004). Displacement of Canada’s largest public illicit drug market in response to a police crackdown. CMAJ. 170:1551–1556.
Woody, G. E., Donnell, D., Seage, G. R., Metzger, D., Marmor, M., Koblin, B. A., Buchbinder, S., Gross, M., Stone, B., and Judson, F.N. (1999). Non-injection substance use correlates with risky sex among men having sex with men: data from HIVNET. Drug Alcohol Depend. 53:197–205.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+ Business Media, Inc.
About this chapter
Cite this chapter
Ompad, D., Fuller, C. (2005). The Urban Environment, Drug Use, and Health. In: Galea, S., Vlahov, D. (eds) Handbook of Urban Health. Springer, Boston, MA . https://doi.org/10.1007/0-387-25822-1_7
Download citation
DOI: https://doi.org/10.1007/0-387-25822-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-23994-1
Online ISBN: 978-0-387-25822-5
eBook Packages: MedicineMedicine (R0)